Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Interim Management Statement

13 Nov 2008 07:00

RNS Number : 0570I
Dialight PLC
13 November 2008
 



Date:

Embargoed until 07.00 am, Thursday 13 November 2008

Contacts:

Roy Burton - Group Chief Executive 

Cathy Buckley - Finance Director

Dialight PLC

Tel: 01480 447490 

Christopher Theis

Canaccord Adams Limited

Tel: 020 7050 6500

Alistair Mackinnon-Musson 

Nathan Field

Hudson Sandler

Tel: 020 7796 4133

Email: dialight@hspr.com

DIALIGHT PLC

Interim Management Statement

Dialight plc, the UK based leader in Applied LED Technology, today publishes its Interim Management Statement relating to the period from 1 July, 2008.

Dialight consists of two business segments:-

 

Signals/Illumination which includes Traffic and Rail Signals, Obstruction Lights and the new product area of Solid State Lighting

Components comprising Light Emitting Diode ("LED") Indication Components and Electromagnetic Disconnects ('smart' meter disconnect switches)

Highlights

Overall trading in line with the Board's expectations despite adverse world economics

Orders for Signals/ Illumination continue to show double digit growth

Growth strategy performing at or above expectations in the Signals/Illumination segment

Indication business within Components reflecting the effect of the economic downturn

Margins stable in spite of inflationary pressure 

Group maintains strong Balance Sheet and positive Operating Cash Flow

Current trading

Dialight's strategy of driving growth through the provision of energy efficient and environmentally friendly lighting products continues to play out in the second half of the year.

Orders for the Signals/Illumination segment continue to grow at double digit rates and as previously reported, our European Traffic Light operation is showing significant growth.

In the Obstruction Lighting Business, sales into the North American Wind Turbine Market and the adoption of our new White Strobe technology are fuelling continued success.

Illumination, and in particular white light, is performing according to plan and sales of our Safesite Hazardous Location Light are encouraging.

In line with the current downturn in the world's economies, orders for our LED Indication product lines are down in the order of 10%, compared to the first halfThe impact of this slowdown has been offset by the strong performance of other parts of the Group and by the strengthening of the US Dollar. 

In summary, the continued good progress in the Signals/Illumination segment gives the Board confidence in maintaining its current outlook on trading for 2008.

NotesThis Interim Management Statement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the statement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

- ENDS -


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBTBRTMMIBBIP
Date   Source Headline
21st Sep 20204:21 pmRNSHolding(s) in Company
1st Sep 20205:51 pmRNSTotal Voting Rights
1st Sep 20205:47 pmRNSDirector/PDMR Shareholding
5th Aug 202010:06 amRNSHolding(s) in Company
5th Aug 202010:01 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSHalf-year Report
31st Jul 202010:00 amRNSHolding(s) in Company
25th Jun 20204:40 pmRNSSecond Price Monitoring Extn
25th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202010:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSTrading Statement
12th Jun 20209:45 amRNSHolding(s) in Company
9th Jun 202010:31 amRNSHolding(s) in Company
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirectorate Change - CFO appointment
21st May 202012:07 pmRNSSecond Price Monitoring Extn
21st May 202012:02 pmRNSPrice Monitoring Extension
20th May 202011:48 amRNSHolding(s) in Company
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
15th May 20201:32 pmRNSDisclosure of rights attaching to equity shares
15th May 202011:53 amRNSHolding(s) in Company
13th May 20201:31 pmRNSResult of AGM
29th Apr 20202:22 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSTrading Statement
28th Apr 20204:01 pmRNSDisclosure of rights attached to equity shares
21st Apr 202012:07 pmRNSSecond Price Monitoring Extn
21st Apr 202012:02 pmRNSPrice Monitoring Extension
21st Apr 20207:00 amRNSTrading Statement
9th Apr 20203:54 pmRNSNotice of AGM
3rd Apr 20209:38 amRNSAnnual Financial Report
1st Apr 202011:47 amRNSTotal Voting Rights
1st Apr 202011:41 amRNSBlock listing Interim Review
1st Apr 202011:36 amRNSDirector Declaration
27th Mar 20201:39 pmRNSDirector/PDMR Shareholding
25th Mar 202010:42 amRNSDirector/PDMR Shareholding
24th Mar 202010:36 amRNSDirector/PDMR Shareholding
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn
17th Mar 20204:39 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSFull year results 2019
16th Mar 20207:00 amRNSHolding(s) in Company
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20204:44 pmRNSSecond Price Monitoring Extn
12th Mar 20204:40 pmRNSPrice Monitoring Extension
11th Mar 20203:26 pmRNSHolding(s) in Company
11th Mar 20203:20 pmRNSHolding(s) in Company
11th Mar 20203:20 pmRNSHolding(s) in Company
10th Mar 20204:41 pmRNSSecond Price Monitoring Extn
10th Mar 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.